Here is one swing stock I have now

Materials↓ ↓

・17.8 months' worth of operating capital (no worries about bankruptcy)

・Preclinical animal data for RLYB3316/31It is scheduled to come out by

・The first clinical trial data for RLYB116Second half of 2024schedule

・We plan to provide analysis results on biomarkers under development in the second half of 2024 and the latest information on future development plans for RLYB116

・Insider purchases are calculatedeightIt's taking place on 5/17

・Everything else

Technical ↓ ↓

It rebounded from the March low of 1.46 and is currently $1.64. It is expected to rise until test data is announced. If things go as expected, at leastAn increase of about 60%You can see it.

Since starting the position, we have been buying more several times within the support area.

Profit margins and loss cuts will be made within the community, and materials that have an impact on stock prices will also be posted as soon as they are announced.

Please take a peek if you like